Skip to main content

Table 1 Summary of laboratory parameters

From: Erratum to: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

 

PBO + MET (n = 137)

DAPA 2.5 mg + MET (n = 137)

DAPA 5 mg + MET (n = 137)

DAPA 10 mg + MET (n = 135)

Sodium (mmol/L)

    

n

72

77

87

93

Baseline

138.9 (2.3)

138.5 (2.9)

138.6 (2.3)

139.1 (2.2)

Change at week 102

-0.04 (2.7)

0.2 (2.8)

0.1 (2.6)

0.1 (2.6)

P vs PBO + MET

 

0.1434

0.1905

0.3978

Potassium (mmol/L)

    

n

72

77

87

93

Baseline

4.35 (0.47)

4.34 (0.46)

4.37 (0.39)

4.37 (0.43)

Change at week 102

-0.08 (0.55)

-0.01 (0.45)

-0.05 (0.35)

-0.07 (0.47)

P vs PBO + MET

 

0.3366

0.4563

0.9918

Serum creatinine (μmol/L)

    

n

72

77

88

93

Baseline

76.9 (17.9)

78.7 (18.1)

79.6 (19.3)

77.8 (17.8)

Change at week 102

-0.9 (10.3)

-1.8 (9.7)

-3.5 (12.7)

-2.7 (10.6)

P vs PBO + MET

 

0.9954

0.4720

0.9032

Serum uric acid (μmol/L) a

    

n

28

35

47

57

Baseline

314 (79)

322 (80)

323 (88)

323 (80)

Change at week 102

-1.78 (54.13)

-55.9 (50.32)

-46.4 (64.36)

-52.9 (64.36)

P vs PBO + MET

 

0.0054

0.0013

0.0002

Blood urea nitrogen (mmol/L)

    

n

72

77

88

93

Baseline

5.33 (1.55)

5.51 (1.41)

5.65 (1.81)

5.34 (1.41)

Change at week 102

0.56 (1.24)

0.70 (1.54)

0.42 (1.87)

0.73 (1.44)

P vs PBO + MET

 

0.2299

0.4169

0.0845

Haematocrit (%)

    

n

71

78

87

93

Baseline

42.61 (3.90)

42.38 (3.99)

42.15 (3.59)

42.88 (3.95)

Change at week 102

-1.43 (3.29)

0.84 (2.53)

1.35 (2.48)

1.54 (2.78)

P vs PBO + MET

 

<0.0001

<0.0001

<0.0001

Haemoglobin (g/L)

    

n

71

78

87

94

Baseline

142.8 (13.45)

142.5 (14.25)

141.6 (12.19)

143.6 (13.10)

Change at week 102

-4.9 (10.14)

1.5 (7.73)

3.1 (8.40)

4.1 (8.84)

P vs PBO + MET

 

<0.0001

<0.0001

<0.0001

Systolic blood pressure (mm Hg)

    

n

72

78

88

94

Baseline

128 (15)

127 (14)

127 (14)

126 (16)

Change at week 102

1.5 (13.7)

0.7 (16.1)

-1.1 (13.2)

-0.3 (15.0)

P vs PBO + MET

 

0.1111

0.0136

0.0067

Diastolic blood pressure (mm Hg)

    

n

72

78

88

94

Baseline

81 (9)

80 (9)

81 (9)

79 (10)

Change at Week 102

-1.0 (7.9)

-0.1 (8.1)

-1.5 (8.1)

-1.2 (10.1)

P vs PBO + MET

 

0.6605

0.2140

0.1075

  1. Data are means (SD) at baseline or mean changes (SD) from baseline at week 102 including data after rescue unless noted. n is the number of treated patients with non-missing baseline and Week 102 values for the specific test. aExcluding data after rescue. Abbreviations: SD standard deviation, SE standard error, PBO placebo, MET metformin, DAPA dapagliflozin.